Cardiovascular diseases remain the main cause for mortality and morbidity in Western countries. The personal societal burden of CVD is devastating as millions suffer from a limited ability to participate in every day life. We have made it our mission to not just improve the life of those who have CVD but also to lower the chances of those with cardiovascular risk factors to ever get severe CVD. We use a three pillar approach to improve our understanding of translational CVD prevention.
1.) We use clinical epidemiological data to associate risk factors with disease severity and development.
2.) We use randomized controlled clinical trials to better understand which interventions are beneficial for the different patient populations.
3.) To solve questions with regards to the biology of how pharmacological and non-pharmacological interventions reduce CVD risk we use animal models and cell cultures.